CIK 0001422142 · Non-accelerated filer<br>Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547850
- Phone
- 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Iyengar Vijay K Director | Grant or award · Stock Option (right to buy) | +76,080 | 76,080 | ||
| 2026-06-12 | Dalal Anupam Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Zhao Baiteng Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Desai Neil Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Aghazadeh Behzad Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Reeve Emma Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Hirmand Mohammad Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Maroun Richard E Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-06-12 | Castelein Caley Director | Grant or award · Stock Option (right to buy) | +38,040 | 38,040 | ||
| 2026-05-14 | Dalal Anupam Director | Grant or award | +1,275,510 | $3.92 | $5.0M | 4,685,912 |
| 2026-05-14 | Lennon David James CHIEF EXECUTIVE OFFICER | Grant or award | +51,021 | $3.92 | $200K | 569,643 |
| 2026-05-14 | Dugan Margaret Chief Medical Officer | Grant or award | +19,132 | $3.92 | $75K | 19,132 |
| 2026-05-14 | BALL BRYAN See remarks | Grant or award | +51,020 | $3.92 | $200K | 448,126 |
| 2026-05-14 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Grant or award | +38,265 | $3.92 | $150K | 333,489 |
| 2026-05-14 | Castelein Caley Director | Grant or award | +255,102 | $3.92 | $1000K | 274,796 |
| 2026-05-14 | Castelein Caley Director | Grant or award · Pre-Funded Warrant (right to buy) | +2,072,756 | $8,124,996.24 | $16841.1B | 2,072,756 |
| 2026-05-12 | Avoro Capital Advisors LLC Director | Grant or award · Pre-funded Warrant (right to buy) | +6,377,714 | $3.92 | $25.0M | 14,710,714 |
| 2026-04-16 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Sale | −141,600 | $4.13 | $585K | 295,224 |
| 2026-04-15 | Giacobello Scott M. CHIEF FINANCIAL OFFICER | Sale | −77,000 | $3.86 | $297K | 436,824 |
| 2026-04-14 | BALL BRYAN See remarks | Sale | −92,460 | $3.64 | $337K | 397,106 |
Page 2 of 9 · 171 trades